Welcome to our dedicated page for FORTUNEX ACQUISITION news (Ticker: FXACU), a resource for investors and traders seeking the latest updates and insights on FORTUNEX ACQUISITION stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect FORTUNEX ACQUISITION's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of FORTUNEX ACQUISITION's position in the market.
FortuneX Acquisition Corporation (Nasdaq: FXACU) announced that underwriters exercised their over-allotment option to buy an additional 1,125,000 units at $10.00 per unit, increasing total units sold to 8,625,000.
Each unit includes one ordinary share and one-half redeemable warrant exercisable at $11.50 per share.
FortuneX Acquisition Corp (Nasdaq: FXACU) closed its initial public offering of 7,500,000 units at $10.00 per unit. Underwriters received a 45-day option to buy up to 1,125,000 additional units at the IPO price to cover over-allotments.
The units began trading on Nasdaq Global Market on May 22, 2026 under ticker FXACU. Each unit includes one ordinary share and one-half redeemable warrant, with each whole warrant exercisable at $11.50 per share.